Risk of drug interactions and prescription appropriateness in elderly patients
In Europe, adverse drug reactions and drug interactions are the cause of considerable morbidity and mortality. In over 75s, hospital access due to adverse drug reactions can be as high as 1 in every 3.
To assess the quality of the prescribed polytherapies in the territory, in terms of the risk of drug interactions and of prescription appropriateness, in over 75s.
Randomly selected patients, over 75s, were analysed among the patients of 3 general practitioners. Their data were analysed with the INTERCheck® software. This software provided the list of drug interactions deriving from the chronic therapies. The program also provided the Beers criteria and the STOPP criteria related to the drugs, highlighting potentially inappropriate drugs.
A total of 188 patients were included in the study. A total of 216 serious or very serious drug interactions have been identified. A total of 92 patients (48.9%) were at risk of at least one serious or very serious interaction. The cut-off of the correlation between the number of drugs taken and the risk of incurring a serious or very serious interaction was found to be 5 (AUC = 0.833, sensitivity = 87%, p < 0.001). Patients on ≥ 4 drugs were at risk of prescriptive inappropriateness with a sensitivity of 84% (AUC = 0.781, p < 0.0001).
Focusing on patients with at least 4 drugs in therapy is the right strategy to reduce the risks associated with polypharmacy.
KeywordsAcetylsalicylic acid Benzodiazepines Escitalopram Furosemide PPI Sertraline
The authors thank Dr. Rinaldi, Dr. Verdi and Dr. Perosino for making their databases, their patients and their work available to the study.
Compliance with ethical standards
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.European Commission (2018) The 2018 Ageing Report: economic and budgetary projections for the EU member states (2016–2070).Google Scholar
- 8.Laursen J, Kornholt J, Betzer C et al (2018) General practitioners’ barriers toward medication reviews in polymedicated multimorbid patients: how can a focus on the pharmacotherapy in an outpatient clinic support GPs? Heal Serv Res Manag Epidemiol 5:2333392818792169. https://doi.org/10.1177/2333392818792169 CrossRefGoogle Scholar
- 16.Johnell K, Klarin I (2007) The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 30:911–918. https://doi.org/10.2165/00002018-200730100-00009 CrossRefPubMedGoogle Scholar